Clinical Trials Directory

Trials / Unknown

UnknownNCT00845403

Antigen-specific Immune Response to Hepatitis B Virus in Utero

Antigen-specific Immune Response to Hepatitis B Virus and Influenza A (H1N1 Strain) in Utero

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
Female
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers.

Detailed description

Despite the development of an effective preventive HBV vaccine, the spread of HBV virus continue, particularly in Asia, where the majority of HBV infection is acquired at birth by vertical transmission from mother to baby. HBV vertical transmission has been hypothesized to cause immune tolerance to HBV and thus promoting the subsequent HBV chronicity. Such hypothesis has never been tested and nothing is known about HBV-specific adaptive immune response occurring before birth in baby born form HBV chronically infected mothers. This study aims to gain an understanding of the key components of the immune response to hepatitis B present in cord blood of HBV infected mothers. The characterization of the HBV immune response in utero will provide informations about the cause of HBV chronicity in Asian patients in the management of baby born from HBsAg+ mothers.

Conditions

Timeline

Start date
2008-09-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2009-02-18
Last updated
2014-01-13

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00845403. Inclusion in this directory is not an endorsement.